Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05818826

Early Versus Conventional Cessation of Hydrocortisone in Septic Shock

Composite Adverse Events Compared Early Versus Conventional Cessation of Hydrocortisone in Patients With Septic Shock: Randomized-controlled Trial

Status
Recruiting
Phase
Phase 2
Study type
Interventional
Enrollment
160 (estimated)
Sponsor
Mahidol University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Septic shock is one of the causes of death in ICU and hospital. Refractory shock is the problem which healthcare providers should recognize though it is difficult to handle with. The corticosteroid called hydrocortisone is one of the treatment in refractory septic shock which requires vasopressor to maintain blood pressure. In recovery phase of septic shock and weaning off vasopressor, there is no definite way to taper off hydrocortisone.

Detailed description

According to secondary outcomes of several studies analyzed in systemic review was shown adverse events from corticosteroid uses including hyperglycemia, hypernatremia, muscle weakness, and superimposed infection. This trials will compare composite adverse events in early versus conventional cessation of hydrocortisone in septic shock.

Conditions

Interventions

TypeNameDescription
DRUGnormal saline solutionPrepare 100 ml of normal saline solution, packed out in the same format, dose, and administration of the drug were exactly the same as in the conventional cessation group.
DRUGHydrocortisone and normal saline solutionPrepare hydrocortisone with normal saline solution 100 ml starts dose at least 200 mg/day according to doctor's order after patient meets the criteria of refractory septic shock then continues conventional cessation of hydrocortisone according to doctor's order after required dose of vasopressor less than 0.1 mcg/kg/min.

Timeline

Start date
2023-07-05
Primary completion
2025-04-01
Completion
2025-05-01
First posted
2023-04-19
Last updated
2024-04-05

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT05818826. Inclusion in this directory is not an endorsement.

Early Versus Conventional Cessation of Hydrocortisone in Septic Shock (NCT05818826) · Clinical Trials Directory